Operating
Stock-Based Comp
Idexx Laboratories Stock-Based Comp increased by 1.4% to $16.34M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $14.62M to $16.34M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 12.3% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.64M | $9.53M | $9.71M | $11.17M | $12.37M | $12.95M | $13.28M | $13.93M | $15.36M | $15.22M | $15.22M | $14.40M | $15.72M | $15.92M | $14.26M | $14.62M | $14.85M | $14.43M | $16.11M | $16.34M |
| QoQ Change | — | -1.1% | +1.9% | +15.0% | +10.7% | +4.7% | +2.6% | +4.9% | +10.3% | -0.9% | -0.0% | -5.4% | +9.2% | +1.3% | -10.4% | +2.5% | +1.6% | -2.8% | +11.6% | +1.4% |
| YoY Change | — | — | — | — | +28.4% | +35.9% | +36.7% | +24.7% | +24.2% | +17.6% | +14.6% | +3.4% | +2.3% | +4.6% | -6.3% | +1.5% | -5.5% | -9.3% | +13.0% | +11.8% |
Range$9.53M – $16.34M
CAGR+11.8%
Avg YoY Growth+12.3%
Median YoY Growth+12.4%
Current Streak2 quarters growth
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Idexx Laboratories's stock-based comp?
- Idexx Laboratories (IDXX) reported stock-based comp of $16.34M in Q1 2026.
- How has Idexx Laboratories's stock-based comp changed year-over-year?
- Idexx Laboratories's stock-based comp increased by 11.8% year-over-year, from $14.62M to $16.34M.
- What is the long-term trend for Idexx Laboratories's stock-based comp?
- Over 4 years (2021 to 2025), Idexx Laboratories's stock-based comp has grown at a 12.3% compound annual growth rate (CAGR), from $37.76M to $60.01M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.